Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

444
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
444
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

230
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
230
Drug Dependence01:17

Drug Dependence

979
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
979
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

160
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
160
Analgesia and Pain Management01:25

Analgesia and Pain Management

518
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
518
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

185
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
185

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Plant-Based Diets and Mental Health Outcomes: A Systematic Review.

Cureus·2025
Same author

Addiction Medicine: Alcohol Use Disorder.

FP essentials·2024
Same author

Addiction Medicine: Benzodiazepine Use Disorder.

FP essentials·2024
Same author

Addiction Medicine: Tobacco Use Disorder.

FP essentials·2024
Same author

Exploring COVID-19 Vaccine Attitudes among Racially and Ethnically Minoritized Communities: Community Partners' and Residents' Perspectives.

International journal of environmental research and public health·2023
Same author

Increasing the Representation of Black Men in Medicine by Addressing Systems Factors.

Academic medicine : journal of the Association of American Medical Colleges·2022

Related Experiment Video

Updated: Jun 7, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K

Addiction Medicine: Opioid Use Disorder.

Michelle A Carroll Turpin1, Steven M Starks2, Maureen O Grissom3

  • 1Department of Biomedical Sciences - Tilman J. Fertitta Family College of Medicine, University of Houston, Houston, TX.

FP Essentials
|November 18, 2024
PubMed
Summary
This summary is machine-generated.

Opioid use disorder (OUD) is a major public health crisis. New legislation expands access to buprenorphine, a key medication for OUD treatment, aiming to reduce overdose deaths and improve recovery outcomes.

More Related Videos

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

16.8K
A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

7.4K

Related Experiment Videos

Last Updated: Jun 7, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.1K
A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

16.8K
A Conflict Model of Reward-seeking Behavior in Male Rats
06:11

A Conflict Model of Reward-seeking Behavior in Male Rats

Published on: February 20, 2019

7.4K

Area of Science:

  • Addiction medicine
  • Neurobiology of addiction
  • Public health policy

Background:

  • Opioid overdose deaths are a critical public health issue in the US.
  • Primary care physicians play a vital role in identifying and managing opioid use disorder (OUD).
  • OUD involves neurobiological dysregulation of the brain's reward pathway, leading to compulsive drug seeking and use.

Purpose of the Study:

  • To highlight the critical need for OUD identification and management in primary care.
  • To discuss the neurobiological underpinnings of addiction and the importance of balancing pain management with OUD monitoring.
  • To emphasize the impact of recent policy changes on treatment accessibility.

Main Methods:

  • Review of the neurobiological mechanisms of addiction.
  • Analysis of the challenges in pain management and OUD monitoring.
  • Examination of the effects of the 2023 Mainstreaming Addiction Treatment Act on buprenorphine prescribing.

Main Results:

  • Most patients with OUD do not receive treatment, despite available interventions.
  • Withdrawal symptoms can be managed with specific medications, aiding recovery.
  • The 2023 Mainstreaming Addiction Treatment Act significantly improves access to medication for OUD across diverse populations.

Conclusions:

  • Medication for opioid use disorder (MOUD) treatment substantially reduces mortality.
  • Policy changes are crucial for expanding access to evidence-based OUD care.
  • Integrated primary care and addiction treatment are essential for addressing the opioid crisis.